Showing results (401-410 of 422) with videos related to

Sort By:
Pageof 43
Multiple Sclerosis and Related Disorders|August 12, 2019
Changing patterns of multiple sclerosis in Korea: Toward a more baseline MRI lesions and intrathecal humoral immune responsesHyun-June Shin, Jae-Won Hyun, Su-Hyun Kim, et al.
The American Journal of Cardiology|February 27, 2023
Myocardial Scar and Revascularization on Mortality in Ischemic Cardiomyopathy (from the Late Gadolinium Enhancement Cardiac Magnetic Resonance Study)Hanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: global health considerationsJorge Correale, Andrew J Solomon, Jeffrey A Cohen, et al.
Multiple Sclerosis and Related Disorders|June 25, 2021
Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residenceRicardo Soares-Dos-Reis, Jessica Li Tsz-Ching, Su-Hyun Kim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated diseaseYou-Ri Kang, Hyunjin Ju, Ki Hoon Kim, et al.
JAMA Neurology|April 4, 2022
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJohn J Chen, Saif Huda, Yael Hacohen, et al.
The Lancet. Neurology|August 21, 2021
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, et al.
JAMA Neurology|September 3, 2024
Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.
Annals of Clinical and Translational Neurology|November 17, 2025
Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis OpticaHadi Salih, Sara Samadzadeh, Charlotte Bereuter, et al.
Journal of Clinical Neurology (Seoul, Korea)|March 11, 2025
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu-Hyun Kim, Ju-Hong Min, Sung-Min Kim, et al.
Pageof 43